These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9712486)
21. The role of stem cell factor in mobilization of peripheral blood progenitor cells: synergy with G-CSF. McNiece IK; Briddell RA; Hartley CA; Andrews RG Stem Cells; 1993 Oct; 11 Suppl 3():83-8. PubMed ID: 7507758 [TBL] [Abstract][Full Text] [Related]
22. Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells. McNiece IK; Briddell RA; Hartley CA; Smith KA; Andrews RG Stem Cells; 1993 Jul; 11 Suppl 2():36-41. PubMed ID: 7691326 [TBL] [Abstract][Full Text] [Related]
23. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice. Carlo-Stella C; Di Nicola M; Magni M; Longoni P; Milanesi M; Stucchi C; Cleris L; Formelli F; Gianni MA Cancer Res; 2002 Nov; 62(21):6152-7. PubMed ID: 12414641 [TBL] [Abstract][Full Text] [Related]
24. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor. Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358 [TBL] [Abstract][Full Text] [Related]
25. Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors. Pan L; Bressler S; Cooke KR; Krenger W; Karandikar M; Ferrara JL Biol Blood Marrow Transplant; 1996 Oct; 2(3):126-33. PubMed ID: 9199755 [TBL] [Abstract][Full Text] [Related]
26. Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective. Couban S; Dranitsaris G; Andreou P; Price S; Tinker L; Foley R; Walker IR; Jamal S; Jamal N; Spaner D; Lipton J; Meharchand J; Messner HA Bone Marrow Transplant; 1998 Dec; 22(12):1199-205. PubMed ID: 9894724 [TBL] [Abstract][Full Text] [Related]
27. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation. Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336 [TBL] [Abstract][Full Text] [Related]
28. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF]. Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058 [TBL] [Abstract][Full Text] [Related]
29. Biological characterization of CD34+ cells mobilized into peripheral blood. Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890 [TBL] [Abstract][Full Text] [Related]
30. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies. Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507 [TBL] [Abstract][Full Text] [Related]
31. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation. Arbona C; Prosper F; Benet I; Mena F; Solano C; Garcia-Conde J Bone Marrow Transplant; 1998 Jul; 22(1):39-45. PubMed ID: 9678794 [TBL] [Abstract][Full Text] [Related]
32. Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC). Benet I; Prosper BF; Marugan I; Lluch A; Arbona C; Castillo I; Solano C; Garcia-Conde J Bone Marrow Transplant; 1999 Jun; 23(11):1101-7. PubMed ID: 10382948 [TBL] [Abstract][Full Text] [Related]
33. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation. Bence-Bruckler I; Bredeson C; Atkins H; McDiarmid S; Hamelin L; Hopkins H; Perry G; Genest P; Huebsch L Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693 [TBL] [Abstract][Full Text] [Related]
34. Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice. Nakamura Y; Tajima F; Ishiga K; Yamazaki H; Oshimura M; Shiota G; Murawaki Y Exp Hematol; 2004 Apr; 32(4):390-6. PubMed ID: 15050750 [TBL] [Abstract][Full Text] [Related]
35. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF. Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933 [TBL] [Abstract][Full Text] [Related]
36. Low-dose radiation (LDR) induces hematopoietic hormesis: LDR-induced mobilization of hematopoietic progenitor cells into peripheral blood circulation. Li W; Wang G; Cui J; Xue L; Cai L Exp Hematol; 2004 Nov; 32(11):1088-96. PubMed ID: 15539087 [TBL] [Abstract][Full Text] [Related]
37. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1. Dreger P; Viehmann K; Steinmann J; Eckstein V; Müller-Ruchholtz W; Löffler H; Schmitz N Exp Hematol; 1995 Feb; 23(2):147-54. PubMed ID: 7530212 [TBL] [Abstract][Full Text] [Related]
38. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood. Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors. Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634 [TBL] [Abstract][Full Text] [Related]
40. Improved granulocyte colony-stimulating factor mobilization of hemopoietic progenitors using cytokine combinations in primates. Larsen SR; Chng K; Battah F; Martiniello-Wilks R; Rasko JE Stem Cells; 2008 Nov; 26(11):2974-80. PubMed ID: 18719223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]